
MCG researchers move forward with breakthrough tear fluid research
“Scientists have found that there is a lot of molecular information in the tear fluid which we can correlate with health and disease,” says Ashok Sharma, PhD.
Augusta University plans to expand its animation program to include an additional 21 faculty members in the Department of Art and Design, which will make it possible to attract about 400 more animation students in the coming years.

“Scientists have found that there is a lot of molecular information in the tear fluid which we can correlate with health and disease,” says Ashok Sharma, PhD.

“Scientists have found that there is a lot of molecular information in the tear fluid which we can correlate with health and disease,” says Ashok Sharma, PhD.




“Scientists have found that there is a lot of molecular information in the tear fluid which we can correlate with health and disease,” says Ashok Sharma, PhD.



TUNE IN






STAY INFORMED
Jag Mobile is a one-stop virtual location for all need-to-know information and a centralized resource for other apps. This will include news and alerts, department updates, emergency information, health resources, student updates and more.
Stay connected and download “Jag Mobile by AU” today!
The annual event was held Sept. 7 on the Summerville Campus.

The book is designed for current instructors of public administration, political science and social science.

The hearings will be hosted in person in the Jaguar Student Activities Center Coffeehouse, Room 235, with a livestream option available.

Mozart’s “Die Zauberflöte (The Magic Flute)” will be performed by the Augusta University Opera Initiative, under the direction of Díana Thompson-Brewer, DMA, on Friday, March 22, and Saturday, March 23, at the Maxwell Performing Arts Theatre.

Lance Hunter, PhD, said the algorithm TikTok uses can play a major role in informational warfare on two fronts.

The grant awarded for Chadli’s research focuses on a specific protein, UNC45A, that can be used as a promising novel immunotherapeutic target in treating triple-negative breast cancer (TNBC).













